Botulinum Toxin Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Botulinum toxin A, and Botulinum toxin B); Gender (Male, and Female); Application ( Medical, and Aesthetic); End User (Hospitals, Dermatology Clinics, and Spas and Cosmetic Centers), and Geography

Report Code: TIPRE00019625 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Botulinum toxin is a protein that is the produced by the Clostridium bacterium and its related species. This toxin helps in preventing the release of neurotransmitter acetylcholine that can cause paralysis. The botulinum toxin injection in used in a number of non-invasive cosmetic surgeries. The availability of minimally invasive surgeries, improving quality of life, and the presence of highly qualified surgeons have contributed in the volume of surgeries using botulinum toxin injections globally.

MARKET DYNAMICS

Factors driving the growth of the botulinum toxin injection market are rising application of botulinum toxin injection in therapeutic and cosmetic surgeries, and rise in the number of product approvals. However, high cost of minimally invasive procedures and side-effects associated with these surgeries is likely to hamper the growth of the market.

MARKET SCOPE

The "Botulinum Toxin Injection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of botulinum toxin injection market with detailed market segmentation by of product, gender, application, and end user. The botulinum toxin injection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in botulinum toxin injection market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The botulinum toxin injection market is segmented on the basis of product, gender, application, and end user. On the basis of product, the market is categorized as botulinum toxin A, and botulinum toxin B. On the basis of gender, the market is categorized as male, and female. On the basis of application, the market is categorized as medical, and aesthetic. On the basis of end user the market is categorized as hospitals, dermatology clinics, spas & cosmetic centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the botulinum toxin injection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The botulinum toxin injection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting botulinum toxin injection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the botulinum toxin injection market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the botulinum toxin injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from botulinum toxin injection market are anticipated to have lucrative growth opportunities in the future with the rising demand for botulinum toxin injection in the global market. Below mentioned is the list of few companies engaged in the botulinum toxin injection market.

The report also includes the profiles of key players in botulinum toxin injection market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

  •  Hugel, Inc.
  •  AbbVie
  •  Revance Therapeutics, Inc.
  •  Allergan
  •  Eisai Co., Ltd.
  •  Evolus, Inc.
  •  Medytox, Inc.
  •  Hugh Source International Ltd.
  •  Merz Pharma
  •  Ipsen

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Botulinum Toxin Injection Market - By Product
1.3.2 Botulinum Toxin Injection Market - By Gender
1.3.3 Botulinum Toxin Injection Market - By Application
1.3.4 Botulinum Toxin Injection Market - By End User
1.3.5 Botulinum Toxin Injection Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BOTULINUM TOXIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BOTULINUM TOXIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BOTULINUM TOXIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. BOTULINUM TOXIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. BOTULINUM TOXIN INJECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BOTULINUM TOXIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BOTULINUM TOXIN A
7.3.1. Overview
7.3.2. Botulinum toxin A Market Forecast and Analysis
7.4. BOTULINUM TOXIN B
7.4.1. Overview
7.4.2. Botulinum toxin B Market Forecast and Analysis
8. BOTULINUM TOXIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - GENDER
8.1. OVERVIEW
8.2. GENDER MARKET FORECASTS AND ANALYSIS
8.3. MALE
8.3.1. Overview
8.3.2. Male Market Forecast and Analysis
8.4. FEMALE
8.4.1. Overview
8.4.2. Female Market Forecast and Analysis
9. BOTULINUM TOXIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MEDICAL
9.3.1. Overview
9.3.2. Medical Market Forecast and Analysis
9.4. AESTHETIC
9.4.1. Overview
9.4.2. Aesthetic Market Forecast and Analysis
10. BOTULINUM TOXIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DERMATOLOGY CLINICS
10.4.1. Overview
10.4.2. Dermatology Clinics Market Forecast and Analysis
10.5. SPAS AND COSMETIC CENTERS
10.5.1. Overview
10.5.2. Spas and Cosmetic Centers Market Forecast and Analysis
11. BOTULINUM TOXIN INJECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Botulinum Toxin Injection Market Overview
11.1.2 North America Botulinum Toxin Injection Market Forecasts and Analysis
11.1.3 North America Botulinum Toxin Injection Market Forecasts and Analysis - By Product
11.1.4 North America Botulinum Toxin Injection Market Forecasts and Analysis - By Gender
11.1.5 North America Botulinum Toxin Injection Market Forecasts and Analysis - By Application
11.1.6 North America Botulinum Toxin Injection Market Forecasts and Analysis - By End User
11.1.7 North America Botulinum Toxin Injection Market Forecasts and Analysis - By Countries
11.1.7.1 United States Botulinum Toxin Injection Market
11.1.7.1.1 United States Botulinum Toxin Injection Market by Product
11.1.7.1.2 United States Botulinum Toxin Injection Market by Gender
11.1.7.1.3 United States Botulinum Toxin Injection Market by Application
11.1.7.1.4 United States Botulinum Toxin Injection Market by End User
11.1.7.2 Canada Botulinum Toxin Injection Market
11.1.7.2.1 Canada Botulinum Toxin Injection Market by Product
11.1.7.2.2 Canada Botulinum Toxin Injection Market by Gender
11.1.7.2.3 Canada Botulinum Toxin Injection Market by Application
11.1.7.2.4 Canada Botulinum Toxin Injection Market by End User
11.1.7.3 Mexico Botulinum Toxin Injection Market
11.1.7.3.1 Mexico Botulinum Toxin Injection Market by Product
11.1.7.3.2 Mexico Botulinum Toxin Injection Market by Gender
11.1.7.3.3 Mexico Botulinum Toxin Injection Market by Application
11.1.7.3.4 Mexico Botulinum Toxin Injection Market by End User
11.2. EUROPE
11.2.1 Europe Botulinum Toxin Injection Market Overview
11.2.2 Europe Botulinum Toxin Injection Market Forecasts and Analysis
11.2.3 Europe Botulinum Toxin Injection Market Forecasts and Analysis - By Product
11.2.4 Europe Botulinum Toxin Injection Market Forecasts and Analysis - By Gender
11.2.5 Europe Botulinum Toxin Injection Market Forecasts and Analysis - By Application
11.2.6 Europe Botulinum Toxin Injection Market Forecasts and Analysis - By End User
11.2.7 Europe Botulinum Toxin Injection Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Botulinum Toxin Injection Market
11.2.7.1.1 Germany Botulinum Toxin Injection Market by Product
11.2.7.1.2 Germany Botulinum Toxin Injection Market by Gender
11.2.7.1.3 Germany Botulinum Toxin Injection Market by Application
11.2.7.1.4 Germany Botulinum Toxin Injection Market by End User
11.2.7.2 France Botulinum Toxin Injection Market
11.2.7.2.1 France Botulinum Toxin Injection Market by Product
11.2.7.2.2 France Botulinum Toxin Injection Market by Gender
11.2.7.2.3 France Botulinum Toxin Injection Market by Application
11.2.7.2.4 France Botulinum Toxin Injection Market by End User
11.2.7.3 Italy Botulinum Toxin Injection Market
11.2.7.3.1 Italy Botulinum Toxin Injection Market by Product
11.2.7.3.2 Italy Botulinum Toxin Injection Market by Gender
11.2.7.3.3 Italy Botulinum Toxin Injection Market by Application
11.2.7.3.4 Italy Botulinum Toxin Injection Market by End User
11.2.7.4 Spain Botulinum Toxin Injection Market
11.2.7.4.1 Spain Botulinum Toxin Injection Market by Product
11.2.7.4.2 Spain Botulinum Toxin Injection Market by Gender
11.2.7.4.3 Spain Botulinum Toxin Injection Market by Application
11.2.7.4.4 Spain Botulinum Toxin Injection Market by End User
11.2.7.5 United Kingdom Botulinum Toxin Injection Market
11.2.7.5.1 United Kingdom Botulinum Toxin Injection Market by Product
11.2.7.5.2 United Kingdom Botulinum Toxin Injection Market by Gender
11.2.7.5.3 United Kingdom Botulinum Toxin Injection Market by Application
11.2.7.5.4 United Kingdom Botulinum Toxin Injection Market by End User
11.2.7.6 Rest of Europe Botulinum Toxin Injection Market
11.2.7.6.1 Rest of Europe Botulinum Toxin Injection Market by Product
11.2.7.6.2 Rest of Europe Botulinum Toxin Injection Market by Gender
11.2.7.6.3 Rest of Europe Botulinum Toxin Injection Market by Application
11.2.7.6.4 Rest of Europe Botulinum Toxin Injection Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Botulinum Toxin Injection Market Overview
11.3.2 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis
11.3.3 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis - By Gender
11.3.5 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Botulinum Toxin Injection Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Botulinum Toxin Injection Market
11.3.7.1.1 Australia Botulinum Toxin Injection Market by Product
11.3.7.1.2 Australia Botulinum Toxin Injection Market by Gender
11.3.7.1.3 Australia Botulinum Toxin Injection Market by Application
11.3.7.1.4 Australia Botulinum Toxin Injection Market by End User
11.3.7.2 China Botulinum Toxin Injection Market
11.3.7.2.1 China Botulinum Toxin Injection Market by Product
11.3.7.2.2 China Botulinum Toxin Injection Market by Gender
11.3.7.2.3 China Botulinum Toxin Injection Market by Application
11.3.7.2.4 China Botulinum Toxin Injection Market by End User
11.3.7.3 India Botulinum Toxin Injection Market
11.3.7.3.1 India Botulinum Toxin Injection Market by Product
11.3.7.3.2 India Botulinum Toxin Injection Market by Gender
11.3.7.3.3 India Botulinum Toxin Injection Market by Application
11.3.7.3.4 India Botulinum Toxin Injection Market by End User
11.3.7.4 Japan Botulinum Toxin Injection Market
11.3.7.4.1 Japan Botulinum Toxin Injection Market by Product
11.3.7.4.2 Japan Botulinum Toxin Injection Market by Gender
11.3.7.4.3 Japan Botulinum Toxin Injection Market by Application
11.3.7.4.4 Japan Botulinum Toxin Injection Market by End User
11.3.7.5 South Korea Botulinum Toxin Injection Market
11.3.7.5.1 South Korea Botulinum Toxin Injection Market by Product
11.3.7.5.2 South Korea Botulinum Toxin Injection Market by Gender
11.3.7.5.3 South Korea Botulinum Toxin Injection Market by Application
11.3.7.5.4 South Korea Botulinum Toxin Injection Market by End User
11.3.7.6 Rest of Asia-Pacific Botulinum Toxin Injection Market
11.3.7.6.1 Rest of Asia-Pacific Botulinum Toxin Injection Market by Product
11.3.7.6.2 Rest of Asia-Pacific Botulinum Toxin Injection Market by Gender
11.3.7.6.3 Rest of Asia-Pacific Botulinum Toxin Injection Market by Application
11.3.7.6.4 Rest of Asia-Pacific Botulinum Toxin Injection Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Botulinum Toxin Injection Market Overview
11.4.2 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis
11.4.3 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis - By Gender
11.4.5 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Botulinum Toxin Injection Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Botulinum Toxin Injection Market
11.4.7.1.1 South Africa Botulinum Toxin Injection Market by Product
11.4.7.1.2 South Africa Botulinum Toxin Injection Market by Gender
11.4.7.1.3 South Africa Botulinum Toxin Injection Market by Application
11.4.7.1.4 South Africa Botulinum Toxin Injection Market by End User
11.4.7.2 Saudi Arabia Botulinum Toxin Injection Market
11.4.7.2.1 Saudi Arabia Botulinum Toxin Injection Market by Product
11.4.7.2.2 Saudi Arabia Botulinum Toxin Injection Market by Gender
11.4.7.2.3 Saudi Arabia Botulinum Toxin Injection Market by Application
11.4.7.2.4 Saudi Arabia Botulinum Toxin Injection Market by End User
11.4.7.3 U.A.E Botulinum Toxin Injection Market
11.4.7.3.1 U.A.E Botulinum Toxin Injection Market by Product
11.4.7.3.2 U.A.E Botulinum Toxin Injection Market by Gender
11.4.7.3.3 U.A.E Botulinum Toxin Injection Market by Application
11.4.7.3.4 U.A.E Botulinum Toxin Injection Market by End User
11.4.7.4 Rest of Middle East and Africa Botulinum Toxin Injection Market
11.4.7.4.1 Rest of Middle East and Africa Botulinum Toxin Injection Market by Product
11.4.7.4.2 Rest of Middle East and Africa Botulinum Toxin Injection Market by Gender
11.4.7.4.3 Rest of Middle East and Africa Botulinum Toxin Injection Market by Application
11.4.7.4.4 Rest of Middle East and Africa Botulinum Toxin Injection Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Botulinum Toxin Injection Market Overview
11.5.2 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis
11.5.3 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis - By Product
11.5.4 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis - By Gender
11.5.5 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis - By Application
11.5.6 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis - By End User
11.5.7 South and Central America Botulinum Toxin Injection Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Botulinum Toxin Injection Market
11.5.7.1.1 Brazil Botulinum Toxin Injection Market by Product
11.5.7.1.2 Brazil Botulinum Toxin Injection Market by Gender
11.5.7.1.3 Brazil Botulinum Toxin Injection Market by Application
11.5.7.1.4 Brazil Botulinum Toxin Injection Market by End User
11.5.7.2 Argentina Botulinum Toxin Injection Market
11.5.7.2.1 Argentina Botulinum Toxin Injection Market by Product
11.5.7.2.2 Argentina Botulinum Toxin Injection Market by Gender
11.5.7.2.3 Argentina Botulinum Toxin Injection Market by Application
11.5.7.2.4 Argentina Botulinum Toxin Injection Market by End User
11.5.7.3 Rest of South and Central America Botulinum Toxin Injection Market
11.5.7.3.1 Rest of South and Central America Botulinum Toxin Injection Market by Product
11.5.7.3.2 Rest of South and Central America Botulinum Toxin Injection Market by Gender
11.5.7.3.3 Rest of South and Central America Botulinum Toxin Injection Market by Application
11.5.7.3.4 Rest of South and Central America Botulinum Toxin Injection Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BOTULINUM TOXIN INJECTION MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BOTULINUM TOXIN INJECTION MARKET, KEY COMPANY PROFILES
14.1. HUGEL, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBVIE
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. REVANCE THERAPEUTICS, INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ALLERGAN
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. EISAI CO., LTD.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. EVOLUS, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MEDYTOX, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. HUGH SOURCE INTERNATIONAL LTD.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. MERZ PHARMA
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. IPSEN
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Hugel, Inc.
2. AbbVie
3. Revance Therapeutics, Inc.
4. Allergan
5. Eisai Co., Ltd.
6. Evolus, Inc.
7. Medytox, Inc.
8. Hugh Source International Ltd.
9. Merz Pharma
10. Ipsen
TIPRE00019625
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking